Join
Live feed
·
PRReleasevia Quantisnow
4D pharma plc logo

4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma

ByQuantisnow·Wall Street's wire, on your screen.
LBPS· 4D pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LBPS (4D pharma plc) and more on Quantisnow.

4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma | Quantisnow